Providing patient-centered comprehensive care to long-term cancer survivors may lead to reduced total healthcare expenditures. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.
Focusing on quality and quality measurements has the potential to reduce costs, increase quality, and deliver more value to patients, consumers, and customers.
The study examined the variation in devices used (desktop/laptop computer, mobile device, or both device types) by patients of different racial/ethnic backgrounds to access the online patient portal.
We assessed challenges and barriers to annual diabetic eye examinations for a managed care Medicaid population and make recommendations to improve population-level screening.
A family-based intervention targeting negative and/or inaccurate illness perceptions in patients with poorly controlled type 2 diabetes was effective in improving glycemic control.
This study examines patterns of high-risk prescribing in the elderly Medicare Advantage population and demonstrates that the practice varies widely by geography and drug class.
This study compares health care costs and health services utilization patterns of patients receiving care in accountable care organization (ACO), patient-centered medical home (PCMH), hybrid (ACO + PCMH), and standard (neither ACO/PCMH) facilities.
Adding a sodium-glucose co-transporter 2 (SGLT2) inhibitor dominated switching to a glucagon-like peptide 1 receptor agonist over the lifetimes of patients with type 2 diabetes not at glycated hemoglobin A1c target after treatment with metformin plus a dipeptidyl peptidase-4 inhibitor.
In the debate of administrative expenses for public and private Medicare, we show incompatibility and extend the analysis to income, benefits, and loss ratio comparisons.
This analysis of paid claims from a physician hospital organization demonstrates that the Vermedx Diabetes Information System improves healthcare costs for adults with diabetes.
The heterogeneous nature of care processes and patients should be taken into account in both the design and evaluation of disease management programs for diabetes.
Flatiron Health recently conducted a retrospective review of the Oncology Care Model, discovering what's working, what isn't, and what this could mean for the future.
We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.
A scalable chronic kidney disease (CKD) quality improvement intervention demonstrated feasibility, decreased hospitalization, and reduced costs. These preliminary results support innovation in CKD by commercial health plans.
Treating hospitalists effectively identify and efficiently address early postdischarge problems through a single, brief telephone encounter.